XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock and Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Non-controlling Interests
Balance at beginning of period (in shares) at Dec. 31, 2023   167.4      
Balance at beginning of period at Dec. 31, 2023   $ 1,624 $ (2,540) $ 1,640 $ 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings $ (38)     (39) 1
Other comprehensive income (loss) (13)   (13)    
Issuance of common stock and stock options exercised (in shares)   1.0      
Issuance of common stock and stock options exercised   $ (5)      
Share repurchase program (in shares)   (0.1)      
Share repurchase program       (39)  
Share-based compensation expenses   $ 56      
Dividends declared       (163)  
Balance at ending of period (in shares) at Mar. 30, 2024   168.3      
Balance at end of period at Mar. 30, 2024   $ 1,675 (2,553) 1,399 16
Balance at beginning of period (in shares) at Dec. 31, 2024   168.6      
Balance at beginning of period at Dec. 31, 2024 1,719 $ 1,942 (2,539) 2,300 16
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings 432     430 2
Other comprehensive income (loss) $ 39   39    
Issuance of common stock and stock options exercised (in shares)   0.7      
Issuance of common stock and stock options exercised   $ (90)      
Share repurchase program (in shares) (0.7) (0.7)      
Share repurchase program $ (325)     (325)  
Share-based compensation expenses   $ 66      
Dividends declared       (182)  
Balance at ending of period (in shares) at Mar. 29, 2025   168.6      
Balance at end of period at Mar. 29, 2025 $ 1,659 $ 1,918 $ (2,500) $ 2,223 $ 18